R. W. Bilous - Concepedia

Author

R. W. Bilous

Newcastle University

Also Known As

A. Yildirir, R Bilous, R W Bilous, R. Bilous, R. W. Bilous, R.W Bilous, R.W. Bilous, Rudolph W Bilous

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Newcastle University Guy's Hospital Royal Victoria Infirmary Middlesbrough College University of Oxford

About

R. W. Bilous is an author at Newcastle University specializing in medicine, diabetes, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	810
2	Health Sciences	3	3	279
3	Engineering	1	1	11
4	Public Health	1	1	175
5	Biochemistry	1	1	10

R. W. Bilous

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes Giancarlo Viberti, R. W. Bilous, David Mackintosh, BMJ HypertensionNephrologyMetabolic SyndromeRenal FunctionChronic Kidney Disease	1983	256
Monitoring glomerular function in diabetic nephropathy G C Viberti, R. W. Bilous, David Mackintosh, The American Journal of Medicine Renal FunctionRenal DiseaseMedicineDiabetesDiabetic Kidney Disease	1983	186
Microvascular disease: what does the UKPDS tell us about diabetic nephropathy? R. W. Bilous Diabetic Medicine Microvascular DiseaseIntensive BloodRenal FunctionPublic HealthMicrovascular Dysfunction	2008	175
Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross‐over trial in people with Type 1 diabetes Simon Ashwell, Stephanie A. Amiel, R. W. Bilous, Diabetic Medicine	2006	117
HUMAN INSULIN PRODUCED BY RECOMBINANT DNA TECHNOLOGY: SAFETY AND HYPOGLYCÆMIC POTENCY IN HEALTHY MEN H. Keen, John C. Pickup, R. W. Bilous, The Lancet Insulin ManagementDiabetesDna ReplicationBiomedical EngineeringInsulin Delivery	1980	113
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial Natalie Staplin, Richard Haynes, PK Judge, The Lancet Diabetes & Endocrinology	2023	74
Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. John C. Pickup, P. D. Home, R. W. Bilous, BMJ Metabolic SyndromeTranslational MedicineDiabetes ManagementInsulin ManagementDiabetes	1981	68
Safety of continuous subcutaneous insulin infusion: Metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion J. C. Pickup, Giancarlo Viberti, R. W. Bilous, Diabetologia Metabolic SyndromeGlycaemic AutoregulationDiabetes ManagementInsulin ManagementDiabetes	1982	47
Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog®) Nitin Roper, R. W. Bilous Diabetic Medicine	1998	34

Page 1